Ryo Sato

2.2k citations
107 papers · 1.7k indexed · 1 hit paper · h-index 18

Ryo Sato

95 papers receiving 1.6k citations

Hit Papers

Evidence for Biochemically Different Types of Vesicles in...6941966202619862006200400600

Peers

Ryo Sato
Comparison fields: 5 of 117
  • Pharmacology 559
  • Biochemistry 151
  • Urology 121
  • Clinical Biochemistry 110
  • Oncology 318
Replace Vladisav Stefanović with:
Vladisav Stefanović Serbia
Masuhiro Nishimura Japan
Bicheng Chen China
Lijian Tao China
Roger Gaedigk United States
Shigekazu Takemura Japan
Sun-Young Ahn United States
Lena Ekström Sweden
Sabine Weiskirchen Germany
Natascha C. Nüssler Germany
Ryo Sato relative to Vladisav Stefanović Serbia Vladisav Stefanović's profile →
Citations per field
00.5×4.0×
Vladisav Stefanović · 1×
Citations per year

Countries citing papers authored by Ryo Sato

Since Specialization
Citations

This map shows the geographic impact of Ryo Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Sato more than expected).

Fields of papers citing papers by Ryo Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Sato. The network helps show where Ryo Sato may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ryo Sato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryo Sato Line = papers co-authored together Ryo Sato links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20240
4 20242
5 20230
6 20232
7 20216
8 20215
9 20199
10 20175
11 20164
12 201518
13 201513
14
Effect of angiotensin II on matrix metalloproteinase-2 secretion from human umbilical vein endothelial cells
20141
15 20128
16 20127
17 20104
18 200812
19 20089
20 20076

About Ryo Sato

Ryo Sato is a scholar working on Urology, Hepatology and Rheumatology, having authored 107 papers that have together received 1.7k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (12 papers), Pelvic floor disorders treatments (7 papers), Urological Disorders and Treatments (7 papers), Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Urinary and Genital Oncology Studies (6 papers), Blood Pressure and Hypertension Studies (6 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Pharmacology (559 citations), Biochemistry (151 citations) and Urology (121 citations). Ryo Sato has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yoshio Imai, Akio Ito, Yusuke Tomita, Akira Asano, Takuro Sakagami, Tokunori Ikeda, Hiroshi Okada, Shigehiro Soh, Gaku Arai and Satoru Shimizu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026